SCHEMBL7415012

SCHEMBL7415012

COC(=O)C(CC(=O)O)NC(=O)c1ccc(-c2ccccc2S(C)(=O)=O)cc1

nearest known ligand 0.46

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP26A1 O43174 1/20 0.46
RAB9A P51151 2/20 0.44
GAA P10253 1/20 0.44
CASP1 P29466 1/20 0.44
CA2 P00918 3/20 0.44
CA1 P00915 2/20 0.44
CYCS P99999 1/20 0.43
CTSA P10619 1/20 0.41
PTGS2 P35354 1/20 0.41
F10 P00742 2/20 0.41
ADAMTS4 O75173 1/20 0.40
ADAMTS5 Q9UNA0 1/20 0.40
ROCK2 O75116 1/20 0.40
ALDH1A1 P00352 2/20 0.40
NPC1 O15118 1/20 0.40
ITGAV P06756 1/20 0.40
CYP3A4 P08684 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7464416 0.88 CA1 (0.47) CYP26A1RAB9AGAACA2CA1
SCHEMBL7417679 0.87 CASP1 (0.51) CYP26A1RAB9AGAACASP1CA2
SCHEMBL7417684 0.86 CASP1 (0.44) CYP26A1RAB9AGAACASP1CA2
SCHEMBL23967346 0.80 GAA (0.54) CYP26A1RAB9AGAACASP1CA2
SCHEMBL7418216 0.80 F10 (0.56) RAB9AGAAF10ALDH1A1NPC1
SCHEMBL7423070 0.76 USP30 (0.49) RAB9AGAACA2CA1F10
Trifluoroacetic Acid SCHEMBL6165833 0.75 F10 (0.58) F10
SCHEMBL5782496 0.74 ITGA4 (0.55)
SCHEMBL890515 0.72 PTGS2 (0.49) RAB9ACA2CA1PTGS2ALDH1A1
SCHEMBL29788178 0.72 PTGS2 (0.49) RAB9ACA2CA1PTGS2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1235807-A1 B-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR XA Millennium Pharmaceuticals, Inc. (US) 2002-09-04 EP disclosed
WO-2001038309-A1 β-AMINO ACID-, ASPARTIC ACID- AND DIAMINOPROPIONIC-BASED INHIBITORS OF FACTOR Xa COR THERAPEUTICS, INC. (US) 2001-05-31 WO disclosed